Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Hiangkiat Tan, MS, BSPharm
Director, HealthCore, Inc,
Wilmington, DE
Director, HealthCore, Inc, Wilmington, DE
Authored Items
Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs for Patients with Newly Diagnosed Systolic versus Diastolic Heart Failure
Chi Nguyen, PhD
,
Xian Zhang, PhD
,
Thomas Evers, PhD
,
Vincent J. Willey, PharmD
,
Hiangkiat Tan, MS, BSPharm
,
Thomas P. Power, MD, FACC, MRCPI
September 2020 Vol 13, No 4
in
Clinical
,
Original Research
Cardiovascular-Related Healthcare Resource Utilization and Costs in Patients with Hypertension Switching from Metoprolol to Nebivolol
Stephanie Chen, PhD
,
Michael F. Murphy, MD, PhD
,
An-Chen Fu, MS, BSPharm
,
Rahul Jain, PhD
,
Hiangkiat Tan, MS, BSPharm
April 2015, Vol 8, No 2
in
Clinical
Last modified: May 11, 2015